Activation of protease‑activated receptor‑2 is associated with increased expression of inflammatory factors in the adipose tissues of obese mice

mengmeng li,xiaoming yang,yadong zhang,liang chen,hanyu lu,xiaobo li,lianhua yin,xiuling zhi

DOI: https://doi.org/10.3892/mmr.2015.4179

IF: 3.423

2015-01-01

Molecular Medicine Reports

Abstract:Previous studies have indicated that mast cells are critical for the pathogenesis of inflammatory diseases. Proteases released from mast cells have been reported to stimulate protease-activated receptors (PAR), which induces microleakage and widespread inflammation. In order to investigate the pro-inflammatory effect of PAR-2 activation on adipose inflammation in obese mice, the varying distributions of macrophages and PAR-2 in adipose tissue samples were compared between C57BL/6J (C-57) and obese mice [B6(D)-Lepr(db)/J, BKS (D)-Lepr(db)/J and B6.V-Lep(ob)/J (ob/ob)] using immunohistochemical staining. Murine primary adipo-cytes and bone marrow-derived macrophages (BMDMs) were used and the alterations in expression levels of inflammatory factors, induced by PAR-2 activation, were detected by reverse transcription-quantitative polymerase chain reaction and ELISA. In addition, the migratory capacity of primary BMDMs and the macrophage cell line, RAW264.7 were evaluated by co-culture with primary adipocytes. The current study demonstrated a larger number of macrophages in the adipose tissues of obese mice compared with C-57 mice. Furthermore, PAR-2 expression was detected in various adipose tissues of mice and the protein expression levels of PAR-2 were observed to be significantly higher in the total adipose tissues of ob/ob mice when compared with the C-57 mice. The expression levels of inflammatory factors were increased in adipocytes and macrophages, and enhanced migratory ability was observed in macrophages pretreated with PAR-2 agonists. The data of the current study suggests that PAR-2 is involved in the process of obesity-associated chronic low-grade systemic inflammation, which indicates that the PAR-2 signaling pathway may be a potential target for the treatment of obesity and its associated diseases.